Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.
Schnabel RB., Marinelli EA., Arbelo E., Boriani G., Boveda S., Buckley CM., Camm AJ., Casadei B., Chua W., Dagres N., de Melis M., Desteghe L., Diederichsen SZ., Duncker D., Eckardt L., Eisert C., Engler D., Fabritz L., Freedman B., Gillet L., Goette A., Guasch E., Svendsen JH., Hatem SN., Haeusler KG., Healey JS., Heidbuchel H., Hindricks G., Hobbs FDR., Hübner T., Kotecha D., Krekler M., Leclercq C., Lewalter T., Lin H., Linz D., Lip GYH., Løchen ML., Lucassen W., Malaczynska-Rajpold K., Massberg S., Merino JL., Meyer R., Mont L., Myers MC., Neubeck L., Niiranen T., Oeff M., Oldgren J., Potpara TS., Psaroudakis G., Pürerfellner H., Ravens U., Rienstra M., Rivard L., Scherr D., Schotten U., Shah D., Sinner MF., Smolnik R., Steinbeck G., Steven D., Svennberg E., Thomas D., True Hills M., van Gelder IC., Vardar B., Palà E., Wakili R., Wegscheider K., Wieloch M., Willems S., Witt H., Ziegler A., Daniel Zink M., Kirchhof P.
AimsDespite marked progress in the management of atrial fibrillation (AF), detecting AF remains difficult and AF-related complications cause unacceptable morbidity and mortality even on optimal current therapy.Methods and resultsThis document summarizes the key outcomes of the 8th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eighty-three international experts met in Hamburg for 2 days in October 2021. Results of the interdisciplinary, hybrid discussions in breakout groups and the plenary based on recently published and unpublished observations are summarized in this consensus paper to support improved care for patients with AF by guiding prevention, individualized management, and research strategies. The main outcomes are (i) new evidence supports a simple, scalable, and pragmatic population-based AF screening pathway; (ii) rhythm management is evolving from therapy aimed at improving symptoms to an integrated domain in the prevention of AF-related outcomes, especially in patients with recently diagnosed AF; (iii) improved characterization of atrial cardiomyopathy may help to identify patients in need for therapy; (iv) standardized assessment of cognitive function in patients with AF could lead to improvement in patient outcomes; and (v) artificial intelligence (AI) can support all of the above aims, but requires advanced interdisciplinary knowledge and collaboration as well as a better medico-legal framework.ConclusionsImplementation of new evidence-based approaches to AF screening and rhythm management can improve outcomes in patients with AF. Additional benefits are possible with further efforts to identify and target atrial cardiomyopathy and cognitive impairment, which can be facilitated by AI.